» Authors » Peter M Hopkins

Peter M Hopkins

Explore the profile of Peter M Hopkins including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 28
Citations 1956
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu R, Miura K, Chambers D, Hopkins P, Proby C, Bibee K, et al.
Transplant Direct . 2023 Jun; 9(7):e1492. PMID: 37305652
Methods: Patients enrolled by a transplant-clinic study nurse completed baseline questionnaires and received sun-safety brochures. For the 12-mo intervention, transplant physicians were alerted to provide standard sun-protection advice (use of...
2.
Gordon L, Hopkins P, Chambers D, Green A
J Heart Lung Transplant . 2023 May; 42(10):1437-1444. PMID: 37244434
Background: Skin cancers are a major source of morbidity in lung transplant recipients, but the relative costs associated with their treatment are unknown. Methods: We prospectively followed 90 lung transplant...
3.
Divithotewala C, Sweeney E, Burke A, Graves B, Stewart A, Whiley D, et al.
Transpl Infect Dis . 2023 Mar; 25(3):e14058. PMID: 36974436
Mycoplasma hominis and Ureaplasma species infections in the post-transplant setting are believed to be donor-derived and can be associated with poor outcomes. Difficulty in culturing and identifying these organisms is...
4.
Divithotawela C, Pham A, Bell P, Ledger E, Tan M, Yerkovich S, et al.
J Heart Lung Transplant . 2021 Jul; 40(9):951-959. PMID: 34226118
Background: Chronic Lung Allograft Dysfunction (CLAD) limits long-term survival following lung transplantation. Colonization of the allograft by Pseudomonas aeruginosa is associated with an increased risk of CLAD and inferior overall...
5.
Chaparro C, Hopkins P, Schwarz C
J Cyst Fibros . 2019 Jun; 18(3):305-306. PMID: 31153582
No abstract available.
6.
Miura K, Vail A, Chambers D, Hopkins P, Ferguson L, Grant M, et al.
J Heart Lung Transplant . 2018 Oct; 38(1):59-65. PMID: 30352778
Background: Lung transplant recipients (LTRs) are at very high risk of skin cancer. Omega-3 fatty acids (FAs) are anti-inflammatory and immune-modulating and could potentially reduce this risk. We assessed the...
7.
Crespo M, McCarthy D, Hopkins P, Clark S, Budev M, Bermudez C, et al.
J Heart Lung Transplant . 2018 Mar; 37(5):548-563. PMID: 29550149
Airway complications remain a major cause of morbidity and mortality after cardiothoracic transplantation. The reported incidence of airway ischemic complications varies widely, contributed to by the lack of a universally...
8.
Glaspole I, Chapman S, Cooper W, Ellis S, Goh N, Hopkins P, et al.
Respirology . 2017 Feb; 22(5):950-956. PMID: 28166611
Background And Objective: Studies analysing the effect of worsening pulmonary physiological impairment in idiopathic pulmonary fibrosis (IPF) with respect to quality of life have been limited to single centres or...
9.
Gallagher H, Sarwar G, Tse T, Sladden T, Hii E, Yerkovich S, et al.
J Heart Lung Transplant . 2015 Jul; 34(11):1442-8. PMID: 26186804
Background: Erratic tacrolimus blood levels are associated with liver and kidney graft failure. We hypothesized that erratic tacrolimus exposure would similarly compromise lung transplant outcomes. This study assessed the effect...
10.
Trotter M, Hopkins P
J Thorac Dis . 2014 Dec; 6(11):1640-53. PMID: 25478204
Advanced chronic obstructive pulmonary disease (COPD) is a significant cause of morbidity. Treatment options beyond conventional medical therapies are limited to a minority of patients. Lung volume reduction surgery (LVRS)...